EUVIMEDEUVIMED entdecken
Crossref

Sequencing Therapies in Non-Hodgkin Lymphomas

F. Brianne Buchanan, PA-C, Tatjana Grgic, PharmD, BCOP, CPP

Journal of the Advanced Practitioner in Oncology · 27.02.2026 · 17 (2)

DOI: 10.6004/jadpro.2026.17.2.12 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the Advanced Practitioner in Oncology, online erschienen am 27.02.2026. Verfasst von F. Brianne Buchanan und 5 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Oncology advanced practitioners treating relapsed or refractory (R/R) B-cell non-Hodgkin lymphomas (NHLs) are practicing in a rapidly evolving landscape with options expanding to include BTK inhibitors, bispecific antibodies, and CAR T-cell therapies. At JADPRO Live 2025, speakers discussed sequencing and how mechanistic, safety, financial, logistical, and quality-of-life factors shape decision-making.

Zitieren

APA

Buchanan, F. B., PA-C, Grgic, T., PharmD, BCOP, & CPP (2026). Sequencing Therapies in Non-Hodgkin Lymphomas. Journal of the Advanced Practitioner in Oncology, 17(2). https://doi.org/10.6004/jadpro.2026.17.2.12

Vancouver

Buchanan FB, PA-C, Grgic T, PharmD, BCOP, CPP. Sequencing Therapies in Non-Hodgkin Lymphomas. Journal of the Advanced Practitioner in Oncology. 2026;17(2). doi:10.6004/jadpro.2026.17.2.12

BibTeX
@article{Buchanan2026,
  author = {Buchanan, F. Brianne and PA-C and Grgic, Tatjana and PharmD and BCOP and CPP},
  title = {Sequencing Therapies in Non-Hodgkin Lymphomas},
  journal = {Journal of the Advanced Practitioner in Oncology},
  year = {2026},
  volume = {17},
  number = {2},
  doi = {10.6004/jadpro.2026.17.2.12}
}
Kostenlos starten →